These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 29465699

  • 21. The Impact of Varying Numbers of Quadrivalent Human Papillomavirus Vaccine Doses on Anogenital Warts in the United States: A Database Study.
    Zeybek B, Lin YL, Kuo YF, Rodriguez AM.
    J Low Genit Tract Dis; 2018 Jul; 22(3):189-194. PubMed ID: 29762430
    [Abstract] [Full Text] [Related]

  • 22. Impacts of Human Papillomavirus Immunization Programs on Rates of Anogenital Warts in British Columbia, Canada, 2000 to 2017.
    Lukac CD, Donken R, Otterstatter M, Mazo O, Wong S, Marra F, Smith L, Naus M, Money D, Krajden M, Grennan T, Gilbert M, Wong J, Ogilvie GS.
    Sex Transm Dis; 2020 Oct; 47(10):691-697. PubMed ID: 32649583
    [Abstract] [Full Text] [Related]

  • 23. Impact of HPV vaccination on anogenital warts and respiratory papillomatosis.
    Wangu Z, Hsu KK.
    Hum Vaccin Immunother; 2016 Jun 02; 12(6):1357-62. PubMed ID: 27217191
    [Abstract] [Full Text] [Related]

  • 24. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
    Navarro-Illana E, López-Lacort M, Navarro-Illana P, Vilata JJ, Diez-Domingo J.
    Vaccine; 2017 Jun 05; 35(25):3342-3346. PubMed ID: 28499554
    [Abstract] [Full Text] [Related]

  • 25. Increasing incidence of anogenital warts with an urban-rural divide among males in Manitoba, Canada, 1990-2011.
    Thompson LH, Nugent Z, Blanchard JF, Ens C, Yu BN.
    BMC Public Health; 2016 Mar 03; 16():219. PubMed ID: 26939696
    [Abstract] [Full Text] [Related]

  • 26. Evaluation of vaccination herd immunity effects for anogenital warts in a low coverage setting with human papillomavirus vaccine-an interrupted time series analysis from 2005 to 2010 using health insurance data.
    Thöne K, Horn J, Mikolajczyk R.
    BMC Infect Dis; 2017 Aug 14; 17(1):564. PubMed ID: 28806926
    [Abstract] [Full Text] [Related]

  • 27. Time-trend of hospitalizations for anogenital warts in Veneto region in the HPV vaccination era: a cross sectional study (2007-2018).
    Cocchio S, Prandi GM, Furlan P, Bertoncello C, Fonzo M, Saia M, Baldovin T, Baldo V.
    BMC Infect Dis; 2020 Nov 18; 20(1):857. PubMed ID: 33208109
    [Abstract] [Full Text] [Related]

  • 28. Human Papillomavirus Vaccine Effectiveness Against Incident Genital Warts Among Female Health-Plan Enrollees, United States.
    Hariri S, Schuler MS, Naleway AL, Daley MF, Weinmann S, Crane B, Newcomer SR, Tolsma D, Markowitz LE.
    Am J Epidemiol; 2018 Feb 01; 187(2):298-305. PubMed ID: 28641366
    [Abstract] [Full Text] [Related]

  • 29. Monitoring vaccine and non-vaccine HPV type prevalence in the post-vaccination era in women living in the Basilicata region, Italy.
    Carozzi F, Puliti D, Ocello C, Anastasio PS, Moliterni EA, Perinetti E, Serradell L, Burroni E, Confortini M, Mantellini P, Zappa M, Dominiak-Felden G.
    BMC Infect Dis; 2018 Jan 15; 18(1):38. PubMed ID: 29334901
    [Abstract] [Full Text] [Related]

  • 30. Effectiveness of varying number of doses and timing between doses of quadrivalent HPV vaccine against severe cervical lesions.
    Dehlendorff C, Sparén P, Baldur-Felskov B, Herweijer E, Arnheim-Dahlström L, Ploner A, Uhnoo I, Kjaer SK.
    Vaccine; 2018 Oct 15; 36(43):6373-6378. PubMed ID: 30249423
    [Abstract] [Full Text] [Related]

  • 31. Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).
    Hidalgo-Tenorio C, Ramírez-Taboada J, Gil-Anguita C, Esquivias J, Omar-Mohamed-Balgahata M, SamPedro A, Lopez-Ruz M, Pasquau J.
    AIDS Res Ther; 2017 Jul 18; 14(1):34. PubMed ID: 28720147
    [Abstract] [Full Text] [Related]

  • 32. Impact of a single-age cohort human papillomavirus vaccination strategy in Catalonia, Spain: Population-based analysis of anogenital warts in men and women.
    Brotons M, Monfil L, Roura E, Duarte-Salles T, Casabona J, Urbiztondo L, Cabezas C, Bosch FX, de Sanjosé S, Bruni L.
    Prev Med; 2020 Sep 18; 138():106166. PubMed ID: 32565118
    [Abstract] [Full Text] [Related]

  • 33. Quadrivalent vaccine-targeted human papillomavirus genotypes in heterosexual men after the Australian female human papillomavirus vaccination programme: a retrospective observational study.
    Chow EPF, Machalek DA, Tabrizi SN, Danielewski JA, Fehler G, Bradshaw CS, Garland SM, Chen MY, Fairley CK.
    Lancet Infect Dis; 2017 Jan 18; 17(1):68-77. PubMed ID: 27282422
    [Abstract] [Full Text] [Related]

  • 34. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
    Lurie S, Mizrachi Y, Chodick G, Katz R, Schejter E.
    Gynecol Oncol; 2017 Aug 18; 146(2):299-304. PubMed ID: 28602548
    [Abstract] [Full Text] [Related]

  • 35. Epidemiology of human papillomavirus on anogenital warts in Portugal - The HERCOLES study.
    Azevedo J, Pista A, Lisboa C, Santo I, Azevedo L, Cunha MJ, HERCOLES Study Group.
    J Eur Acad Dermatol Venereol; 2017 Aug 18; 31(8):1342-1348. PubMed ID: 28485812
    [Abstract] [Full Text] [Related]

  • 36. Human Papillomavirus and Genital Warts: A Review of the Evidence for the 2015 Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines.
    Park IU, Introcaso C, Dunne EF.
    Clin Infect Dis; 2015 Dec 15; 61 Suppl 8():S849-55. PubMed ID: 26602622
    [Abstract] [Full Text] [Related]

  • 37. Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine(Gardasil®) in the prevention of premalignant genital lesions, genital cancer, and genital warts in women.
    McCormack PL, Joura EA.
    BioDrugs; 2011 Oct 01; 25(5):339-43. PubMed ID: 21942919
    [Abstract] [Full Text] [Related]

  • 38. Could the human papillomavirus vaccine prevent recurrence of ano-genital warts?: a systematic review and meta-analysis.
    Husein-ElAhmed H.
    Int J STD AIDS; 2020 Jun 01; 31(7):606-612. PubMed ID: 32438856
    [Abstract] [Full Text] [Related]

  • 39. Low prevalence of vaccine-type HPV infections in young women following the implementation of a school-based and catch-up vaccination in Quebec, Canada.
    Goggin P, Sauvageau C, Gilca V, Defay F, Lambert G, Mathieu-C S, Guenoun J, Comète E, Coutlée F.
    Hum Vaccin Immunother; 2018 Jan 02; 14(1):118-123. PubMed ID: 29049007
    [Abstract] [Full Text] [Related]

  • 40. Prevention of anal condyloma with quadrivalent human papillomavirus vaccination of older men who have sex with men.
    Swedish KA, Goldstone SE.
    PLoS One; 2014 Jan 02; 9(4):e93393. PubMed ID: 24714693
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.